Pfizer taps oncology head Boshoff as Dolsten’s chief scientific officer successornews2024-11-20T12:15:08+00:00November 20th, 2024|Endpoints News|
Carolyn Bertozzi’s new biotech debuts with $30M for immunotherapy worknews2024-11-20T12:00:53+00:00November 20th, 2024|Endpoints News|
Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagshipnews2024-11-20T12:00:40+00:00November 20th, 2024|Endpoints News|
Pfizer partners with two more Flagship biotechs on obesity, cancernews2024-11-20T11:30:45+00:00November 20th, 2024|Endpoints News|
GSK plots regulatory filings for PBC itch after positive Phase 3 readoutnews2024-11-19T20:53:31+00:00November 19th, 2024|Endpoints News|
NICE has ‘done all we can’ to negotiate for Enhertu coveragenews2024-11-19T20:49:51+00:00November 19th, 2024|Endpoints News|
FDA rejects Astellas’ effort to support longer use of Izervay news2024-11-19T19:50:39+00:00November 19th, 2024|Endpoints News|
FDA raises safety questions on AstraZeneca’s bleeding reversal agentnews2024-11-19T19:37:40+00:00November 19th, 2024|Endpoints News|
Chinese drugmaker receives FDA warning letter after management hindered inspectionnews2024-11-19T19:37:21+00:00November 19th, 2024|Endpoints News|
BeiGene settles final suit over future Brukinsa genericsnews2024-11-19T19:17:26+00:00November 19th, 2024|Endpoints News|
